Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

St-elevation Myocardial Infarction (STEMI) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

2 recruiting trials for St-elevation Myocardial Infarction (STEMI). Eligibility criteria explained in plain English.

TrialFinderData lists 2 St-elevation Myocardial Infarction (STEMI) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Saglik Bilimleri Universitesi (1), Second Affiliated Hospital, School of Medicine, Zhejiang University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Digital Content-Supported Medical Nutrition Therapy (behavioral, 1 trial), followed by Drug-coated balloon (DCB), Drug-eluting stent (DES).

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors

Track St-elevation Myocardial Infarction (STEMI) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07427199

Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With...

This study is designed to investigate the effect of a nutrition program supported by digital content on heart function in patients who have experienced a heart attack with...

Sponsor: Saglik Bilimleri UniversitesiEnrolling: 2001 location
RECRUITINGNCT06742125

Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction

Acute ST-segment elevation myocardial infarction (STEMI) is a life-threatening emergency requiring immediate intervention. The incidence of premature coronary artery disease...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 12441 location

Frequently Asked Questions

There are currently 2 clinical trials for St-elevation Myocardial Infarction (STEMI), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for St-elevation Myocardial Infarction (STEMI), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for St-elevation Myocardial Infarction (STEMI), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.